E6-15755. Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of premarket approval applications Start Printed Page 56158(PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the agency's Division of Dockets Management.

    ADDRESSES:

    Submit written requests for copies of summaries of safety and effectiveness to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in Table 1 of this document when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Thinh Nguyen, Center for Devices and Radiological Health (HFZ-402), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-2186, ext. 152.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    I. Background

    In the Federal Register of January 30, 1998 (63 FR 4571), FDA published a final rule that revised 21 CFR 814.44(d) and 814.45(d) to discontinue individual publication of PMA approvals and denials in the Federal Register. Instead, the agency now posts this information on the Internet on FDA's home page at http://www.fda.gov. FDA believes that this procedure expedites public notification of these actions because announcements can be placed on the Internet more quickly than they can be published in the Federal Register, and FDA believes that the Internet is accessible to more people than the Federal Register.

    In accordance with section 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the act. The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.

    The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from April 1, 2006, through June 30, 2006. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.

    Table 1.—List of Safety and Effectiveness Summaries for Approved PMAs Made Available From April 1, 2006, through June 30, 2006

    PMA No./Docket No.ApplicantTrade NameApproval Date
    P050021/2006M-0161QLT, Inc.CERALAS I LASER & CERALINK SLIT LAMP ADAPTERDecember 20, 2005
    P040052/2006M-0264MonoGen, Inc.MONOPREP PAP TEST (MPPT)March 3, 2006
    P040028/2006M-0148Medispectra, Inc.LUMA CERVICAL IMAGING SYSTEMMarch 16, 2006
    P050012/2006M-0200Dexcom, Inc.DEXCOM (STS) CONTINUOUS GLUCOSE MONITORING SYSTEMMarch 24, 2006
    P050026/2006M-0162QLT, Inc.QUALTEL ACTIVIS LASER & ZSL30 ACT, ZSL120 ACT, and HSBMBQ ACT SLIT LAMP ADAPTERSApril 4, 2006
    P030008(S4)/2006M-0199SurgiVision Refractive ConsultantsWAVELIGHT ALLEGRETTO WAVE EXCIMER LASER SYSTEMApril 19, 2006
    P040033/2006M-0193Smith & Nephew OrthopaedicsBIRMINGHAM HIP RESURFACING (BHR) SYSTEMMay 9, 2006
    P050047/2006M-0235Inamed Corp.JUVEDERM 24HV, JUVEDERM 30, and JUVEDERM 30HV GEL IMPLANTSJune 2, 2006

    II. Electronic Access

    Persons with access to the Internet may obtain the documents at http://www.fda.gov/​cdrh/​pmapage.html.

    Start Signature

    Dated: September 15, 2006.

    Linda S. Kahan,

    Deputy Director, Center for Devices and Radiological Health.

    End Signature End Supplemental Information

    [FR Doc. E6-15755 Filed 9-25-06; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
09/26/2006
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E6-15755
Pages:
56157-56158 (2 pages)
Docket Numbers:
Docket Nos. 2006M-0161, 2006M-0264, 2006M-0148, 2006M-0200, 2006M-0162, 2006M-0199, 2006M-0193, 2006M-0235
PDF File:
e6-15755.pdf